Wobble Genomics

Edinburgh, United Kingdom Founded: 2020 • Age: 6 yrs
A platform is provided for nucleic acid biomarker discovery.

About Wobble Genomics

Wobble Genomics is a Healthcare company based in Edinburgh (United Kingdom) founded in 2020 by Richard Kuo. A platform is provided for nucleic acid biomarker discovery. Wobble Genomics has raised $12.46 million across 2 funding rounds from investors including Mercia, BGFG and Eos Capital Advisors. The company has 6 employees. Its focus areas include Life Sciences, Genomics, Genomics Research and Biomarker Discovery. Its legal entity is WOBBLE GENOMICS LIMITED.

Company details

Wobble Genomics was founded in 2020 in Edinburgh, United Kingdom, within the genomics sector. A platform for nucleic acid biomarker discovery is offered, incorporating cDNA normalization technology called Level-Up to support non-targeted sequencing for biomarker identification. TAMA RNA sequencing bioinformatics software is also provided to facilitate gene detection. Operations focus on these tools for research applications in the United Kingdom.

  • Headquarters Edinburgh, United Kingdom
  • Employees 6
  • Founders Richard Kuo
  • Sectors
    Healthcare
  • Website wobblegenomics.com
  • Social LinkedIn
  • Legal Name Wobble Genomics Limited
  • Date of Incorporation 06 Apr, 2021
  • Jurisdiction EDINBURGH, UNITED KINGDOM
Key Metrics
  • Total Equity Funding
    $12.46M (USD)

    in 2 rounds

  • Latest Funding Round
    $10.81M (USD), Series A

    Dec 2023

  • Investors
    Mercia

    & 6 more

  • Employee Count
    6

Funding Insights of Wobble Genomics

Wobble Genomics has successfully raised a total of $12.46M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10.81 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $12.46M
  • Total Rounds 2
  • Last Round Series A β€” $10.81M
  • First Round $1.65M

    (Sep 2021)

  • Investors Count 7

All 2 funding rounds of Wobble Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2023$10.81MSeries A–Mercia, BGFG
Sep 2021$1.65MSeed–Eos Advisory
Valuation history

7 investors in total: 7 institutional.

Investors in Wobble Genomics

Wobble Genomics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia, BGFG and Eos Capital Advisors.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Deep tech venture capital firm investing in European and global startups.
iqcapital.vc
oldcollegecapital.co.uk
Investment in science and technology is managed by Eos.
2014eos-advisory.comSt Andrews, Scotland
Investment in Web3 technologies is facilitated by DeepTech Ventures.
2017deeptechventures.ioPfäffikon SZ, Switzerland
Investment management services are provided by Mercia to various clients.
1982mercia.co.uk
Game advertising services are provided by BGFG to clients.
2019bgfg.co.ukManchester, United Kingdom
Advisory services in Consumer, Infrastructure, and Technology sectors.
2011eoscapital.inDelhi, India
Premium access

Investor details for Wobble Genomics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Wobble Genomics

1 people are tracked at Wobble Genomics (1 in leadership); the tracked headcount is 6.

NameRoleGroup
Richard Kuo
FounderLeadership
Premium access

Complete people profiles for Wobble Genomics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Wobble Genomics

3 dated milestones of Wobble Genomics across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Wobble Genomics is founded.
  2. Funding First funding round of $1.7M.
  3. Funding Latest funding round, Series A, of $10.8M.

Web traffic of Wobble Genomics

The website of Wobble Genomics (wobblegenomics.com) receives about 1K visits a month.

  • Monthly visits
    1K

    ▲ 163.9% vs previous month

Top companies in Genomics & Gene Therapy Platforms

2 companies that operate in the same segment as Wobble Genomics (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Wobble Genomics

Premium access

Complete news archive for Wobble Genomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wobble Genomics

Wobble Genomics was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Wobble Genomics is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.

Wobble Genomics is a funded company, having raised a total of $12.46M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.65M, raised on Sep 2021.

Wobble Genomics has 6 employees.

Wobble Genomics was founded in 2020 in Edinburgh, United Kingdom, within the genomics sector. A platform for nucleic acid biomarker discovery is offered, incorporating cDNA normalization technology called Level-Up to support non-targeted sequencing for biomarker identification. TAMA RNA sequencing bioinformatics software is also provided to facilitate gene detection. Operations focus on these tools for research applications in the United Kingdom.

Wobble Genomics has 7 investors. Key investors include Mercia, BGFG, Eos Capital Advisors, IQ Capital, and Old College Capital.

Wobble Genomics operates through Wobble Genomics Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available